Traferox will design, build, and validate a dynamic organ storage system that pumps an oxygenated solution in a donor organ throughout the transport and preservation duration, while maintaining an opt...
Traferox Technologies Inc
9 enregistrements totalisant 1,775,050.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $1,775,050 | 9 enregistrements |
Enregistrements
Traferox will design, manufacture, and validate systems that can perform normothermic ex vivo perfusion of the liver and the heart. In normothermic ex vivo organ perfusion, solid organs are perfused...
A mobile and automated system will be created to implement ex vivo lung perfusion, a technique used to assess lungs in preparation for lung transplant.
Traferox will design, manufacture, and validate a system to perform normothermic ex vivo perfusion of the pancreas. In normothermic ex vivo pancreas perfusion, the excised pancreas is perfused with a...
Traferox has recently developed and commercialized the TorEx Lung Perfusion System. The technology developed and integrated in this system can be used in new clinical applications. This project will...
Clinical development of ex vivo organ perfusion devices
The new Graduate will research, design, implement and test improvements to the perfusion circuit of ex vivo organ perfusion systems, in order to improve Traferox’s current products as well as develop...
The new Graduate will establish manufacturing of the Lung Transport Device. They will also research and test components to monitor and control flow in perfusion circuits, which will be employed in Tr...
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a...